Pharmacovigilance
This course is designed for undergraduate graduates who aspire to deepen their knowledge and skills in the field of pharmacovigilance and clinical trials. The course provides a detailed understanding of drug safety monitoring processes and methodologies used in clinical research, essential for ensuring the efficacy and safety of drug treatments.
The target group of this course includes professionals from various fields of medical and pharmaceutical sciences, such as pharmacists who wish to expand their knowledge in post-marketing drug monitoring, physicians interested in the clinical aspects of pharmaceutical safety, and licensed pharmacy assistants who want to specialize in pharmacovigilance. The course is also aimed at chemists and chemical engineers involved in drug development and analysis, as well as biologists and biochemists who want to better understand the biological impact of drug substances and contribute to clinical trials.
By participating in this course, professionals will acquire advanced skills in drug risk assessment and management, clinical trial data interpretation, and the application of international regulations in the field. Thus, they will be prepared to contribute significantly to improving the safety and effectiveness of medical treatments.
- Organizers: AVANTYO - Institute of Clinical Research
- Location: Online
- Language: Romanian
- Trainer: Prof. Dr. Viorel Robert Ancuceanu
This course is intended for graduates with a bachelor's degree who wish to deepen their knowledge in the field of pharmacovigilance and clinical trials. It is intended for pharmacists, physicians, licensed pharmacy assistants, chemists and chemical engineers, biologists, and biochemists.
Cristina Florescu Moraid President of Clinical Trials Symposium, CEO Avantyo Institute of Clinical Research
Dr Florescu Moraid earned her Medical Doctor degree in 1998 from the Carol Davila University of Medicine and Pharmacy in Bucharest. She was accredited as a Laboratory Medicine Specialist in 2005 and as a Senior Laboratory Medicine Specialist in 2011 by the Romanian College of Physicians.
She completed a Master of Science degree in 2006, the Postgraduate School of Clinical Trials Management in Gdańsk in 2012, and the Postgraduate Leadership Development Programme at the University of Sussex in 2014.
Between 2005 and 2018, Dr Florescu Moraid led clinical trial operations at Synevo Central Lab, the clinical research division of the Swedish Medicover Group, serving as Regional Director for Romania, Moldova, Bulgaria, and Serbia. During this period, she also organised the Synevo Clinical Trials Symposium for ten consecutive years.
Since 2019, she has been the Co-founder of Avantyo - Institute of Clinical Research and the CEO of Camina Medical Experts, providing tailored clinical trial services to pharmaceutical sponsors, CROs, and mid-sized biotech companies.
She is a frequent invited speaker at scientific meetings and a committed advocate for strengthening awareness of the value of clinical trials for patients.
Robert Ancuceanu “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Professor Robert Ancuceanu is a senior academic within the Bucharest Faculty of Pharmacy at the Carol Davila University of Medicine and Pharmacy, where he teaches Cell and Molecular Biology and Pharmaceutical Botany, and is currently a Vice-dean. He holds a PhD in Pharmacy, a Master’s degree in Biostatistics, and a Bachelor’s degree in Law, and has worked across multiple pharmaceutical domains, ranging from academia to industry and regulatory affairs.
He served as Director General of the General Directorate for Pharmaceutics and Medical Devices within the Romanian Ministry of Health and as Vice-president of the Romanian National Medicines Agency. He was a member of the EMA Committee for Human Medicinal Products (CHMP), the Paediatric Committee (PDCO), and an alternate member of the Committee on Herbal Medicinal Products (HMPC), as well as a participant in several national committees and working groups in the pharmaceutical field.
He is a Steering Group member of the TOPRA Product Information and Labelling SPIN. Professor Ancuceanu has published over 100 scientific papers, including 85 indexed in ISI Clarivate, has authored two books, and has contributed as co-author or chapter author to fourteen further volumes.
He is deeply engaged in the application of computational methods within the life sciences, with interests spanning chemoinformatics, bioinformatics, computational biology, and biostatistics. His current H-index is 22, with more than 7,600 citations.
Beyond his broad engagement with the pharmaceutical sciences, Professor Ancuceanu describes himself as a late Renaissance man, with additional interests in law, history, music, programming and computer science, sociology, art, and literature.
For previous events, please access one of the following links.
